Arlene Lusterio
arlenelusterio.bsky.social
Arlene Lusterio
@arlenelusterio.bsky.social
CEO FOUNDER of EmbraceHealthFoundation and EmbraceHealthInnovations.
Pinned
Reposted by Arlene Lusterio
August 13, 2025 at 4:22 PM
Reposted by Arlene Lusterio
October 13, 2025 at 5:41 PM
December 1, 2025 at 4:55 PM
November 30, 2025 at 1:25 AM
November 29, 2025 at 7:37 PM
November 29, 2025 at 5:02 PM
November 28, 2025 at 7:54 PM
Reposted by Arlene Lusterio
November 18, 2025 at 10:21 PM
November 28, 2025 at 3:43 PM
Reposted by Arlene Lusterio
In low-risk patients with MI and early complete revascularization, stopping aspirin after 1 month and continuing P2Y12 monotherapy was noninferior to dual antiplatelet therapy for ischemic outcomes and led to reduced bleeding at 1 year. Full TARGET-FIRST trial results: nej.md/3UKJxS7

#MedSky
November 27, 2025 at 8:01 PM
November 27, 2025 at 4:53 PM
November 26, 2025 at 7:28 PM
November 26, 2025 at 4:50 PM
Reposted by Arlene Lusterio
November 17, 2025 at 3:54 PM
November 26, 2025 at 4:02 PM
Reposted by Arlene Lusterio
Arlene Lusterio (@arlenelusterio)
substack.com
November 13, 2025 at 6:21 PM
November 25, 2025 at 7:03 PM
November 25, 2025 at 4:50 PM